SCHEMBL8029974

SCHEMBL8029974

Cn1c(Cc2ccc(C#N)cc2)nc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
PKM P14618 3/20 0.55
LMNA P02545 5/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 2/20 0.54
CYP2D6 P10635 1/20 0.54
CNR2 P34972 1/20 0.52
OPRM1 P35372 2/20 0.52
KCNJ1 P48048 1/20 0.46
KCNH2 Q12809 1/20 0.46
MAPT P10636 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8029881 0.91 KCNJ1 (0.46) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL6159759 0.90 KMT2A (0.58) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL7981313 0.86 ALDH1A1 (0.44) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL16590350 0.85 ALDH1A1 (0.58) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL590346 0.84 PKM (0.61) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL7377767 0.84 ALDH1A1 (0.53) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL12217716 0.80 ALDH1A1 (0.60) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL8028137 0.80 CNR2 (0.48) KMT2ACNR2SMN1; SMN2
SCHEMBL8032940 0.79 KCNJ1 (0.48) ALDH1A1LMNAKMT2AMEN1CNR2
SCHEMBL8026313 0.78 ABCG2 (0.50) ALDH1A1PKMLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060166-A1 FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS Boehringer Ingelheim Pharma KG (DE) 2000-12-20 EP disclosed
US-6114532-A ANTICOAGULANT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-05 US disclosed
WO-1999040072-A1 FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-08-12 WO disclosed